Advocacy

CHADD is part of a social movement that seeks to shape the conversation on how society treats, accommodates, and views people affected by ADHD. Our movement is made up of countless people affected by ADHD, their families, teachers, friends, and leaders in the fields of ADHD research, education, and mental health. We realize the most effective way to accomplish our goals is through sustained and strategic outreach to policymakers on the state and federal levels.

We are making a difference for families and adults affected ADHD. And we need your help! We want you to be equipped with information to make a difference in your own life, whether that means dealing with issues in the classroom, the boardroom, or your living room.

CALL TO ACTION

Your Support and Advocacy Matters

Your voice matters. Your experience with ADHD matters. Now is the time for you to take action and be an advocate for the ADHD community in whatever way you are able to contribute.

CURRENT ISSUES

CHADD Position Statement on Controlled Substances Measures

July 24, 2017

CHADD has become aware of state and local policies, including legislation and regulations, intended to address the misuse of opioids, but which may have unintended consequences for children and adults prescribed FDA-approved medications to treat attention deficit hyperactivity disorder (ADHD). Read the full statement.

CHADD’s Position on Patient Access to ADHD Medications

May 15, 2017

Medication Access Principles: CHADD ascribes to the following principles regarding access to medications indicated to treat attention deficit / hyperactivity disorder (ADHD). Medication is recognized by the scientific community as a primary treatment to effectively reduce the core symptoms of ADHD.[1] Given the stigma associated with ADHD and common misconceptions about treating the disorder, individuals…

American Health Care Act

May 15, 2017

The House of Representatives had been preparing to vote on the American Health Care Act (AHCA), which would repeal significant portions of the Affordable Care Act (ACA or “Obamacare”) and replace them with alternative coverage policies. At this time, the House is not moving forward with a vote on the AHCA. Read our full report.

Health Insurance Coverage and ADHD

March 24, 2017

In September 2016, CHADD conducted a survey about health insurance coverage and attention deficit hyperactivity disorder (ADHD) in the United States. More than 1500 people from all 50 states and Washington, D.C. took part in the online survey and answered 15 anonymous questions about their personal experiences seeking access to services and medications for their,…

ADVOCACY PARTNERS

FEDERAL GOVERNMENT

ADULT ADHD GUIDELINES DEVELOPMENT

The recent surge in adults seeking care for ADHD, coupled with a steady increase in ADHD medication prescriptions, has underscored the pressing need for diagnostic and treatment guidelines.

To address this issue, CHADD has partnered with the American Professional Society for ADHD and Related Disorders (APSARD) to develop and distribute guidelines in 2025. APSARD is leading the charge in developing the guidelines for review. CHADD is taking the lead in developing resources and toolkits for healthcare providers across the United States to implement the new diagnostic and treatment guidelines.

WEBINARS

Analysis and Impact of Federal Healthcare and Education Policies

Download Slides

Several proposed federal policies have the potential to affect ADHD diagnosis, treatment, and educational support for individuals and families. Experts in ADHD diagnosis and treatment will review research-based responses to the Make America Healthy Again (MAHA) Commission's claims about ADHD. They will also discuss the critical role the US Department of Education plays in supporting students who have ADHD.

Previous Lunch and Learn Webinars

The Importance of Adult ADHD Guidelines

Dr. Peter Jensen, founder of The REACH Institute, is the director of a coalition of organizations developing adult ADHD diagnosis and treatment guidelines for use in the United States, a joint effort of CHADD and APSARD.

For more information on the development of adult guidelines, read The Quest for Clinical Practice Guidelines for ADHD in Adults.

What Is ADHD? How It Affects Children and Adults

Max Wiznitzer, MD, discusses the medical science of ADHD and how it is expressed in children and adults. ADHD impairs many aspects of life, and it is important that the public and policymakers have an understanding of the disorder when addressing laws and policies regarding ADHD and its treatment.

RESOURCES

WHITE PAPER

The Adverse Health Outcomes, Economic Burden, and Public Health Implications of Unmanaged Attention Deficit Hyperactivity Disorder (ADHD): A Call to Action to Improve the Quality of Life and Life Expectancy of People with ADHD

 

Proceedings of the ADHD Public Health Summit
Washington, DC
October 7, 2019

 

Presented by Children and Adults with Attention-Deficit/ Hyperactivity Disorder (CHADD)

TOOLKITS